Literature DB >> 8077551

Influence of anatomic correction for transposition of the great arteries on myocardial perfusion: radionuclide imaging with technetium-99m 2-methoxy isobutyl isonitrile.

A M Hayes1, E J Baker, A Kakadeker, J M Parsons, R P Martin, R Radley-Smith, S A Qureshi, M Yacoub, M N Maisey, M Tynan.   

Abstract

OBJECTIVES: We sought to determine the incidence of late perfusion defects attributable to coronary artery mobilization in patients undergoing anatomic correction for complete transposition of the great arteries.
BACKGROUND: Anatomic correction (arterial switch procedure) is currently the surgical treatment of choice for complete transposition. From its conception, there has been concern about the impact on myocardial perfusion of the coronary artery mobilization and reimplantation involved in the correction. Previous studies have demonstrated myocardial perfusion defects in patients after correction, although a causal relation between coronary mobilization, and perfusion abnormality has not been established.
METHODS: In a case-comparison study designed to test this hypothesis, 29 children underwent imaging with technetium-99m 2-methoxy isobutyl isonitrile (technetium-99m mibi). Ten had undergone anatomic correction (arterial switch group; interval from operation 6.9 +/- 1.42 years [range 4.9 to 9.1]); 9 had required noncoronary open heart surgery for other cardiac lesions (post-bypass group; interval from operation 5.6 +/- 3.6 years [range 1.0 to 13.25]); and 10 had had no surgical procedure (control group). The latter group comprised children with atrial or ventricular septal defects who required a radionuclide study for shunt calculation. Planar studies were performed in all 29 children, and additional tomographic acquisition was achieved in 25. To assess reversibility of perfusion defects both an exercise and a rest planar study were performed in the arterial switch group.
RESULTS: Perfusion abnormalities were observed in seven of the nine children in the postbypass group and in all 10 children in the arterial switch group. The frequency of perfusion defects in these two groups was similar, with at least 25% of the tomographic segments reported being abnormal. The control group had significantly fewer defects than the other two groups (p = 0.02), with only 8% of the tomographic segments judged to be abnormal. In all except one patient in the arterial switch group, the segments reported as abnormal on the planar exercise study were either abnormal or equivocal on the rest study, indicating a fixed abnormality.
CONCLUSIONS: Although the precise etiology of these perfusion abnormalities cannot be defined from this study, these data suggest that their origin is related more to the insult of open heart surgery itself than to the coronary manipulation involved in the arterial switch procedure. The functional importance requires further study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077551     DOI: 10.1016/0735-1097(94)90027-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  Transoesophageal atrial pacing combined with transthoracic two dimensional echocardiography: experience in patients operated on with arterial switch operation for transposition of the great arteries.

Authors:  E De Caro; G P Ussia; M Marasini; G Pongiglione
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

2.  Identifying Subclinical Coronary Abnormalities and Silent Myocardial Ischemia After Arterial Switch Operation.

Authors:  Takeshi Tsuda; Jeanne M Baffa; Jenna Octavio; Bradley W Robinson; Wolfgang Radtke; Tejal Mody; A Majeed Bhat
Journal:  Pediatr Cardiol       Date:  2019-03-09       Impact factor: 1.655

3.  Right ventricle myocardial perfusion scintigraphy: feasibility and expected values in children.

Authors:  Daniel Velasco-Sanchez; Raymond Lambert; Sophie Turpin; Serge Laforge; Anne Fournier; Chantale Lapierre; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2011-10-04       Impact factor: 1.655

Review 4.  Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease.

Authors:  Sara L Partington; Anne Marie Valente; Michael Landzberg; Frederick Grant; Marcelo F Di Carli; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2015-07-01       Impact factor: 5.952

5.  Assessment of radiation dose in nuclear cardiovascular imaging using realistic computational models.

Authors:  Tianwu Xie; Choonsik Lee; Wesley E Bolch; Habib Zaidi
Journal:  Med Phys       Date:  2015-06       Impact factor: 4.071

6.  Long-term fate of the coronary arteries after the arterial switch operation in newborns with transposition of the great arteries.

Authors:  D Bonnet; P Bonhoeffer; J F Piéchaud; Y Aggoun; D Sidi; C Planché; J Kachaner
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

7.  Assessment of left ventricular function long term after arterial switch operation for transposition of the great arteries by dobutamine stress echocardiography.

Authors:  L Hui; A K T Chau; M P Leung; C S W Chiu; Y F Cheung
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

8.  Myocardial perfusion abnormalities in patients occurring more than 1 year after successful univentricular (Fontan surgery) and biventricular repair (complete repair of tetralogy of Fallot).

Authors:  A Priyadarshini; Anita Saxena; Chetan Patel; Vinod K Paul; Rakesh Lodha; Balram Airan
Journal:  Pediatr Cardiol       Date:  2012-10-12       Impact factor: 1.655

9.  Role of myocardial perfusion single photon emission computed tomography in pediatric cardiology practice.

Authors:  P Shanmuga Sundaram; S Padma
Journal:  Ann Pediatr Cardiol       Date:  2009-07

10.  Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteries.

Authors:  T S Hornung; E J Bernard; E T Jaeggi; R B Howman-Giles; D S Celermajer; R E Hawker
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.